Decoding TGF-beta signaling pathways in skin langerhans cells
Decoding TGF-beta signaling pathways in skin langerhans cells
批准号:
10541915
负责人:
QING-SHENG MI
金额:
$37.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-02-01 至 2024-01-31
关键词:
AdultAffectAmino AcidsAntigen-Presenting CellsBCL2 geneBindingBiologyBirthBone MarrowCell MaintenanceCell NucleusCell OntogenyCell physiologyCellular biologyChIP-seqCytoplasmDataDefectDendritic CellsDevelopmentDiseaseEmbryoEmbryonic DevelopmentEpidermisFRAP1 geneFamilyFetal LiverGene ActivationGene DeletionGene MutationGenesGeneticGoalsGrowthHomeostasisITGAM geneImageImmune ToleranceImpairmentIn VitroIndividualInflammationInflammatoryInterruptionLangerhans cellLeadLentivirusLightMAPK8 geneMacrophage Colony-Stimulating Factor ReceptorMaintenanceMediatingMembraneMitogen-Activated Protein KinasesMolecularMusMyelogenousPathway interactionsPeripheralPhosphorylationPhosphotransferasesPopulationProceduresProteinsRUNX3 geneRegulationReportingResearchRoleSignal PathwaySignal TransductionSkinSpecificityTF geneTGF Beta Signaling PathwayTRAF6 geneTestingTransforming Growth Factor betaTransforming Growth FactorsWorkYolk Sacactivating transcription factor 3adaptive immunityblastomere structuredensityexperiencegene functiongene networkin vivomacrophagemonocytemouse modelp38 Mitogen Activated Protein Kinasepostnatalpregnantpromoterreceptorrecruitself-renewalsingle-cell RNA sequencingskin disordertherapeutic targettranscriptome sequencing
中文摘要
摘要
郎格汉斯细胞(LCS)是皮肤上的树突状细胞(DC),控制着两种获得性免疫
以及皮肤的免疫耐受性,并参与多种皮肤病的发生发展。
转化生长因子-β-1(转化生长因子-β-1)是维持和发挥LC功能的重要因子。
转化生长因子β1信号通过与TGFb受体相互作用激活Smad依赖或
调节TGFb1靶基因和细胞功能的Smad非依赖性途径。然而,
信号转导途径、TGFb1介导的LC维持和调控的分子网络
胚胎LC中TGFb1的功能调控及其相关机制
事态发展仍不明朗。我们最近的工作和初步研究表明,TGFb1是
对于胚胎LC发育是绝对必要的,其中转化生长因子β激活的激酶1(Tak1),以及
不是Smads,而是主导的TGFb1信号通路;Tak1,而不是Smads,参与其中
LC生后分化;Smad信号通路在炎症过程中占主导地位
诱导LC再布居。这些结果强烈地表明,不同的TGFb信号通路
在胚胎个体发育与出生后动态平衡或炎症中调节LC-
诱导重新繁殖。在拟议的研究中,将使用不同的特定于空间和时间的
RNA-seq、scRNA-seq、ChIP-seq、
成像流式细胞仪,以及体内/体外慢病毒介导的基因激活和缺失策略,
目的是破译TGFb信号通路和相关的上下文相关的特异性
调节LC个体发育、出生后动态平衡和再繁殖的分子网络。结果
这不仅将加深我们对LC生物学的理解,而且还将有助于
高特异性治疗LC的潜在靶点新探
疾病。
英文摘要
Abstract
Langerhans cells (LCs), the skin residing dendritic cells (DCs), control both adaptive immunity
and immune tolerance in skin and are involved in the development of a variety of skin diseases.
Transforming growth factor-β1 (TGFβ1) is a crucial factor for LC maintenance and function.
TGFβ1 signals through interactions with TGFb receptors to activate either Smad-dependent or
Smad-independent pathways to regulate TGFb1 target genes and cellular function. However, the
signaling pathways, the detailed molecular networks of TGFb1-mediated LC maintenance and
functional regulation, and the specific role of TGFb1 and related mechanisms in embryonic LC
development remain unclear. Our recent work and preliminary studies showed that TGFb1 is
absolutely required for embryonic LC development, in which TGFβ-activated kinase 1 (Tak1), and
not Smads, leads the dominant TGFb1 signaling pathway; that Tak1, not Smads, is involved in
LC postnatal differentiation; and that Smad signaling pathways are dominant during inflammation-
induced LC repopulation. These results strongly suggest that diverse TGFb signaling pathways
mediate LC regulations in embryonic ontogeny versus postnatal homeostasis or inflammation-
induced repopulation. In the proposed studies, will use different spatial- and temporal-specific and
transient inducible gene mutation mouse models combined with RNA-seq, scRNA-seq, ChIP-Seq,
imaging FACS, and in vivo/in vitro lentivirus-mediated gene activation and deletion strategies,
aiming to decipher the context-dependent specificities of TGFb signaling pathways and related
molecular networks that regulate LC ontogeny, postnatal homeostasis, and repopulation. Results
from the proposed studies will not only further our understanding of LC biology, but also will shed
new light on potential therapeutic targets with high specificity for the treatment of LC-related
diseases.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3390/biology12070925
发表时间:
2023-06-28
期刊:
Biology
影响因子:
4.2
作者:
[]
通讯作者:
microRNAs and NKT cell development and function
-
批准号:9241970
-
项目类别:
-
资助金额:$37.42万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Roles of HDAC3 in Epidermal Langerhans Cell Ontogeny and Function
-
批准号:9888305
-
项目类别:
-
资助金额:$33.11万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Serum miRNA Biomarkers of Islet Autoimmunity
-
批准号:9080976
-
项目类别:
-
资助金额:$77.37万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Roles of HDAC3 in Epidermal Langerhans Cell Ontogeny and Function
-
批准号:9222709
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Serum miRNA Biomarkers of Islet Autoimmunity
-
批准号:9248240
-
项目类别:
-
资助金额:$75.19万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Roles of HDAC3 in epidermal Langerhans cell ontogeny and function
-
批准号:9082306
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
microRNAs and NKT cell development and function
-
批准号:9098864
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2015
-
负责人:QING-SHENG MI
-
依托单位:
microRNA as biomarkers for the response to immunotherapy in melanoma
-
批准号:8383931
-
项目类别:
-
资助金额:$15.93万
-
财政年份:2012
-
负责人:QING-SHENG MI
-
依托单位:
microRNA as biomarkers for the response to immunotherapy in melanoma
-
批准号:8549182
-
项目类别:
-
资助金额:$17.97万
-
财政年份:2012
-
负责人:QING-SHENG MI
-
依托单位:
miRNAs and epidermal langerhans cell development and function
-
批准号:7979036
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2010
-
负责人:QING-SHENG MI
-
依托单位:
miRNAs and epidermal langerhans cell development and function
-
批准号:8131739
-
项目类别:
-
资助金额:$16.07万
-
财政年份:2010
-
负责人:QING-SHENG MI
-
依托单位:
海外基金